Beyond Safety and Efficacy: Why Successful Commercialization Does Not Depend Only on Clinical Trials Data
OnlineVyxeos, Glybera, Exubera and Praluent are just a few examples of drugs that received market approval but had limited adoption and did not meet sales expectations. Unfortunately, developing a safe...